ENTERO vs MEESHO: Stock Comparison

Entero Healthcare Solutions Limited vs Meesho Ltd

Live data: 17 July 2026, 3:54 PM IST • Source: NSE and company filings

Meesho Ltd is the larger company by market capitalisation. Entero Healthcare Solutions Limited shows a higher ROE, faster revenue growth and a higher ROCE, while Meesho Ltd shows a lower P/E and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Entero Healthcare Solutions Limited and Meesho Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ENTERO is more favourable on 9 of 13 scored metrics and MEESHO on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
MEESHO is the larger company
₹85,622 Cr vs ₹5,125 Cr
P/E Ratio
MEESHO has a lower P/E
-62.49x vs 45.65x
P/B Ratio
ENTERO has a lower P/B
3.11x vs 19.31x
EPS
ENTERO has higher earnings per share
₹26.38 vs ₹-2.97
Revenue Growth (TTM YoY)
ENTERO has faster revenue growth
42.6% vs 0%
EPS Growth (TTM YoY)
ENTERO has faster EPS growth
9.1% vs 0%
Qtr Sales Growth
MEESHO has stronger quarterly sales growth
47.1% vs 42.6%
Qtr Profit Growth
ENTERO has stronger quarterly profit growth
9.03% vs -56%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricENTEROMEESHO
SectorConsumer Services
IndustryPharmacy Retail

Price

MetricENTEROMEESHO
Live Price₹1,174₹187.87
Day Change-2.6%1.6%
Volume53,3951.17 Cr
52-Week High₹1,390₹254.4
52-Week Low₹944₹125.56
Distance from 52W High-15.54%-26.15%

Valuation

MetricENTEROMEESHO
Market Cap₹5,125 Cr₹85,622 Cr
P/E Ratio45.65x-62.49x
P/B Ratio3.11x19.31x
EPS₹26.38₹-2.97
Book Value₹388.26₹9.61
Dividend Yield0%0%

Growth

MetricENTEROMEESHO
Revenue Growth (TTM YoY)42.6%0%
EPS Growth (TTM YoY)9.1%0%
Qtr Sales Growth42.6%47.1%
Qtr Profit Growth9.03%-56%

Profitability & Leverage

MetricENTEROMEESHO
ROE6.99%-42.3%
ROCE10.6%-35.6%
Net Margin1.75%-10.75%
Operating Margin4.04%-11.8%
Debt to Equity0.4x0.01x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricENTEROMEESHO
Promoter Holding14.41%16.57% 0.19 pp
FII Holding4.03% 1.11 pp4.17% 0.14 pp
DII Holding16.62% 0.2 pp5.55% 0.27 pp
Public Holding26.93% 0.91 pp73.71% 0.05 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Entero Healthcare Solutions Limited and Meesho Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.